Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
Código da empresaACON
Nome da EmpresaAclarion Inc
Data de listagemApr 22, 2022
CEOMr. Brent Ness
Número de funcionários6
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 22
Endereço8181 Arista Place
CidadeBROOMFIELD
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal80021
Telefone18332752266
Sitehttps://aclarion.com/
Código da empresaACON
Data de listagemApr 22, 2022
CEOMr. Brent Ness
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados